✦ LIBER ✦

A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer

✍ Scribed by Peter J. Tobin; Philip Beale; Leesa Noney; Sandy Liddell; Laurent P. Rivory; Stephen Clarke

Book ID: 105992183
Publisher: Springer
Year: 2005
Tongue: English
Weight: 238 KB
Volume: 57
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-0053-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan and doxiflur

Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism

✍ Shoichi Hazama; Atsushi Nagashima; Hiroshi Kondo; Shin Yoshida; Ryoichi Shimizu; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Predictive Role of the UGT1A1, UGT1A7, a

Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

✍ Cecchin, E.; Innocenti, F.; D'Andrea, M.; Corona, G.; De Mattia, E.; Biason, P.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 134 KB